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ABSTRACT:
Long QT syndrome (LQTS) is an inherited ion channelopathy resulting in abnormal ventricular
repolarization and abnormal prolongation of QT interval on the ECG. Syncope, fainting, cardiac arrest,
and sudden death are common manifestations of LQTS. We present a case report that describes a patient
with prolonged QT interval after extrasystoles and a family history of sudden cardiac deaths.
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INTRODUCTION
The long QT syndrome (LQTS) is a disorder
of myocardial repolarization characterized
by a prolonged QT interval on the
electrocardiogram (ECG) and an increased
risk of sudden cardiac death. This syndrome
is associated with an increased risk of a
characteristic life-threatening cardiac
arrhythmia, known as Torsade de Pointes or
"twisting of the points" (TdP). Despite the
availability of genetic analysis, ECG is still
very important tool to establish a diagnosis
of LQTS. We present the case of a young
lady with a strong family history of sudden
cardiac death and remarkable prolongation
of QT interval after PVCs, documented on a
24-hour ECG record.
CASE PRESENTATION
The patient, a 36-years-oldwoman, had a
history of frequent syncopal attacks and
palpitations during the previous two years.
She was referred from the department of
neurology to our clinic for evaluation of
syncope and run of wide QRS tachycardia
on ECG.
Her family history was remarkable,
including a recent sudden death of her sister
at 38 while sleeping and unexplained sudden
deaths of her aunt and cousin (in a traffic
accident) at ages 43 and 38 respectively. Her
routine ECG, echocardiography, and blood
workup were unremarkable and her 24-hour
ECG revealed short run of non-sustained
ventricular tachycardia (two or three
episodes). Based on the ECG, Holter (Figs.
1 and 2), and her clinical history, a
presumed diagnosis of LQTS type 2 was
made. A beta blocker (Metaprolol 200 mg)
was prescribed and an ICD was implanted
for the primary prophylaxis of sudden
cardiac death.
Figure 1. Routine ECG showing normal QT/QTc intervals[Electronic Physician 2010; 2: 104-108] Page 106
Fifure 2. 24hour Holter ECG strip recorded in our patients shows sudden prolongation of QT interval after PVCs
(arrow).
DISCUSSION
Instances of QT prolongation after PVC
were first reported in 1915 and are not
frequently observed in either cardiac
patients or healthy individuals. The
mechanism is unknown, but it is considered
to be related to cardiac memory, similar to
the T-wave changes following intermittent
ventricular pacing, LBBB, or ventricular
pre-excitation (1).
The clinical significance of this is unknown.
Extrasystoles are common in otherwise
healthy young patients. For most, this is a
harmless condition that does not require a
specific therapy. However, the rare patient
who is at risk for lethal arrhythmias must be
identified (2). In this particular case,
structural heart disease was excluded by
echocardiography. Nevertheless, we focused
on symptoms suggestive of
tachyarrhythmias (such as syncope and rapid
heartbeat that terminates abruptly), and her
evident family history of early-age sudden
deaths. Arrhythmic syncope in patients with
long QT syndrome is often misdiagnosed as
vasovagal or hysterical. The patient’s family
members’ early deaths were consistent with
the presence of a familial long QT
syndrome. The long QT syndrome may be
congenital or acquired. Some
pharmacological agents can cause acquired
long QT syndrome. Agents and conditions
that reduce net repolarizing current amplify
the intrinsic spatial dispersion of[Electronic Physician 2010; 2: 104-108] Page 107
repolarization, creating the substrate for the
development of re-entry. The result is a
prolongation of the QT interval, abnormal T
waves, and development of polymorphic re-
entrant ventricular tachycardia displaying
characteristics of Torsades de Pointes (TdP)
(3). These conditions also predispose M-
cells and Purkinje fibers to develop early
afterdepolarization-induced extrasystoles
that are thought to trigger episodes of TdP.
Agents that prolong the QT interval but do
not increase transmural dispersion of
repolarization are not capable of inducing
TdP. The available data suggest that the
principal problem with the long QT
syndrome is the dispersion of repolarization
that often accompanies prolongation of the
QT interval (4).
Figure3. Fatal cardiac events classified according to
the three main triggers in the genotypes (Circulation
103:89, 2001)
As an inheritable channelopathy, family
screening in LQTS is clearly important.
LQTS has been classified based on LQTS
genes and 10 previously identified types of
this pathology. But there is agreement that
LQT1, LQT2 and LQT3 variants account for
greater than 90 percent of all genotyped
patients (5). Triggers for cardiac events
differ strikingly among the genetic variants
of LQTS (6). We have classified our patient
as probable LQT2 type (7) and hence beta
blockers (8, 9) and ICD use was considered
the best course of primary prevention in
management (9) of our patient. The basis of
our diagnosis was the evidence given by
Peter J, Schwartz et al. in their landmark
study “Geno-type-Phenotype Correlation in
Long QT Syndrome” (10). Fatal cardiac
events are also classified according to the
three main triggers in the genotypes (Fig. 3).
CONCLUSIONS
QT interval prolongation after PVCs is a
rare clinical manifestation of LQTS. In our
particular case, the risk of sudden cardiac
death was stratified as high and, according
to the guidelines and experts consensus, we
managed the patient with beta blockers and
ICD insertion. On follow-up patient has
clinically benefited.
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